查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827834

2025年全球性病诊断市场报告

STD Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，性病诊断市场呈现强劲成长势头，市场规模从2024年的99.3亿美元增至2025年的107.7亿美元，复合年增长率达8.5%。预测期内的成长归因于流行病学趋势、医疗基础建设、药物研发、性教育计画以及人口结构变化。

预计未来几年性病诊断市场将快速成长，到2029年将达到159.8亿美元，复合年增长率为10.4%。预测期内的成长可归因于个人化医疗趋势、医疗保健可近性的改善、人口健康策略、远端医疗位健康以及性病患病率的上升。预测期内的主要趋势包括就地检验(POCT)、家用检测套组、多重检测、有针对性的营销和推广、暴露前预防计划以及患病率的上升。

性行为感染传染病 (STD) 诊断涉及检测和识别透过性接触传播的感染疾病。这些诊断程序对于确定个体是否存在 STD 至关重要。

性传染病 (STD) 诊断的主要类别包括披衣菌感染、梅毒、淋病、单纯疱疹病毒、人类乳突病毒、人类免疫力缺乏病毒、软下疳以及其他在实验室和照护现场进行的检测。披衣菌感染检测透过分析尿液样本来检测感染。这种专门的检测用于识别披衣菌感染感染，这是一种常见的细菌性性性行为感染(STI)，透过各种形式的性接触和生殖器暴露传播。这些性传染病诊断适用于医院、诊所、诊断中心和居家医疗机构。

2025年春季，美国关税飙升及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供性传染病诊断市场统计数据，例如全球市场规模、区域份额、性传染病诊断市场中的竞争对手、详细的性传染病诊断细分市场、市场趋势和机会，以及您在性传染病诊断行业取得成功所需的数据。本性传播疾病诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年的预测成长率为10.4%，较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。美国可能会直接感受到这种影响，因为抗原试纸和微流体晶片等关键零件的供应链中断，这些零件来自印度、墨西哥和新加坡等关键地区，可能导致检测套组短缺和诊断延误。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也将更加广泛。

性行为感染传染病 (STD) 的流行是性传染病诊断市场的主要驱动力。性传染病是透过性接触传播的感染疾病，已成为全球关注的健康议题。世界卫生组织 (WHO) 于 2022 年报告称，全球每天诊断出的性行为感染 ) 超过一百万例，包括披衣菌感染、淋病、梅毒和滴虫病，每年约有 3.74 亿新发感染病例。性传染病的日益流行凸显了性传染病诊断在高效分析和检测中的关键作用，从而推动了市场的成长。

预计未来几年，不断增长的医疗保健支出将推动性病诊断市场的成长。医疗保健支出是指特定医疗保健系统或经济体在特定时期内用于医疗保健服务、相关产品和活动的总支出。这种医疗保健支出与性病诊断息息相关，因为它代表了对预防保健的策略性投资，解决了公共卫生优先事项，并有助于个人和社区的整体健康和福祉。例如，英国政府国家统计局在 2024 年 5 月报告称，从 2022 年到 2023 年，医疗保健总支出名义上将增长 5.6%，与 2022 年的 0.9% 增幅相比有显着增长。因此，不断增长的医疗保健支出正在推动性病诊断市场的成长。

性传染病 (STD) 诊断技术的进步是 STD 诊断市场的一大趋势。主要企业正在升级其检测设备和技术，以更快、更准确地诊断性行为感染传染病。例如，2022 年 5 月，美国医疗科技公司碧迪公司 (BD) 宣布推出一款名为「BD CORTM MX/PX 系统」的全自动高通量感染疾病分子诊断平台。该平台整合并自动化了分子实验室工作流程，从样本处理到诊断结果的交付。这个新平台上推出的首个检测产品是 BD CTGCTV2 分子检测，该检测产品能够识别三种最常见的非病毒性行为感染感染 (STI)：披衣菌感染衣原体 (CT)、淋病奈瑟菌 (GC) 和阴道毛滴虫 (TV)。

性病诊断市场的主要企业正致力于开发创新产品，例如即时PCR套件，以满足尚未满足的医疗需求并提高诊断能力。即时PCR套件包含一系列用于进行即时聚合酵素链锁反应（qPCR）的试剂。例如，2023年3月，江苏百福生物科技有限公司推出了霉浆菌支原体即时PCR套件和梅毒螺旋体即时即时PCR套件，分别专门用于检测霉浆菌支原体和梅毒螺旋体。这些套件具有高灵敏度和特异性、易于使用、快速的周转时间，以及在一次测试中检测多种病原体的能力。

2024年2月，印度医疗保健公司Thyrocare收购了Think Health Care，具体金额未揭露。 Thyrocare旨在透过此次收购，从策略上增强其服务范围和市场覆盖，尤其是在居家医疗领域。 Think Healthcare是一家专注于诊断和预防性医疗保健的印度公司，以提供家庭心电图服务而闻名。

性病诊断市场由提供性病诊断测试（例如微生物培养/分离测试、分子检测和免疫测定）的营业单位所获得的收益组成。市场规模包括服务提供者销售或包含在其服务产品中的相关产品的价值。性病诊断市场还包括用于提供性病诊断服务的聚合酵素连锁反应热迴圈仪、PCR、侧向流读取仪（层析法色谱分析）、流式细胞仪、差示光散射仪、吸光度微孔盘读数仪、手机晶片和快速诊断试剂套件的销售。此市场价值为“出厂价”，即产品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球性传染病诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球性病诊断市场：成长率分析
  • 全球性病诊断市场表现：规模与成长，2019-2024
  • 全球性传染病诊断市场预测：规模与成长，2024-2029年，2034年
  • 全球性病诊断：总目标市场（TAM）

第六章 市场细分

  • 全球性传染病诊断市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 披衣菌感染检测
  • 梅毒检测
  • 淋病检查
  • 单纯疱疹病毒检测
  • 人类乳突病毒检测
  • 人类免疫力缺乏病毒检测
  • 软性下疳检查
  • 其他的
  • 全球性病诊断市场：按检测地点、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 实验室检查
  • 照护现场检定 (PoC)
  • 全球性传染病诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断中心
  • 居家医疗
  • 全球性传染病诊断市场：披衣菌感染检测细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 核酸增幅检查（NAAT）
  • 抗原检测
  • 全球性传染病诊断市场：梅毒检测细分、类型、表现及预测（2019-2024、2024-2029、2034）
  • 快速血浆再生（RPR）测试
  • 梅毒螺旋体检测
  • 全球性病诊断市场：淋病检测细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 核酸增幅检查（NAAT）
  • 文化测试
  • 全球性传染病诊断市场：单纯疱疹病毒检测细分，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • PCR检测
  • 血清学检测
  • 全球性传染病诊断市场：人类乳突病毒检测细分市场，按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • HPV DNA检测
  • HPV RNA检测
  • 全球性免疫力缺乏病毒检测细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 抗体检测
  • 抗原或抗体检测
  • 核酸检测（NAT）
  • 全球性软性下疳检测细分市场、类型、绩效及预测（2019-2024、2024-2029、2034）
  • 文化测试
  • 核酸检测
  • 全球性传染病诊断市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 其他新测试

第七章 区域和国家分析

  • 全球性传染病诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球性病诊断市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 性病诊断市场：竞争格局
  • 性病诊断市场：公司简介
    • Siemens AG
    • Abbott Laboratories
    • Qiagen Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG

第31章：其他领先和创新企业

  • Hologic Inc.
  • Bio-Rad Laboratories Inc.
  • Becton Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Biocartis NV
  • Trinity BIoTech PLC
  • Binx Health Inc.
  • NOWDiagnostics Inc.
  • Atlas Genetics Ltd.
  • BioFire Diagnostics LLC
  • BioMerieux SA
  • Chembio Diagnostic Systems Inc.
  • Corgenix Medical Corporation
  • Creative Diagnostics
  • Curetis AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年性病诊断市场：提供新机会的国家
  • 2029年性病诊断市场：细分市场带来新机会
  • 2029年性病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22987u

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The STD diagnostics market research report is one of a series of new reports from The Business Research Company that provides STD diagnostics market statistics, including STD diagnostics industry global market size, regional shares, competitors with a STD diagnostics market share, detailed STD diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the STD diagnostics industry. This STD diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The std diagnostics market size has grown strongly in recent years. It will grow from $9.93 billion in 2024 to $10.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to epidemiological trends, healthcare infrastructure development, pharmaceutical developments, sexual education programs, demographic shifts.

The std diagnostics market size is expected to see rapid growth in the next few years. It will grow to $15.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to personalized medicine trends, healthcare access improvements, population health strategies, telemedicine and digital health, rising incidence of STDs. Major trends in the forecast period include point-of-care testing (POCT) advancements, home testing kits, multiplex testing, targeted marketing and outreach, pre-exposure prophylaxis (prep) programs, rising incidence rates.

The forecast of 10.4% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like antigen test strips and microfluidic chips, sourced from key regions such as India, Mexico, and Singapore, which could lead to shortages in testing kits and delayed diagnosesThe effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The escalating prevalence of sexually transmitted diseases (STDs) is a significant driver propelling the STD diagnostics market forward. STDs, infectious diseases transmitted through sexual contact, have become a global health concern. In 2022, the World Health Organization reported that over 1 million sexually transmitted infections are acquired daily worldwide, with approximately 374 million new infections annually, including chlamydia, gonorrhea, syphilis, and trichomoniasis. The rising incidence of STDs underscores the critical role of STD diagnostics in efficient analysis and testing, driving the market's growth.

The increasing healthcare expenditure is anticipated to drive the growth of the STD diagnostics market in the future. Healthcare expenditure refers to the overall amount of money spent on healthcare services, related goods, and activities within a specific healthcare system or economy over a defined period. This expenditure is relevant to STD diagnostics as it signifies a strategic investment in preventive healthcare, addresses public health priorities, and contributes to overall health and well-being at both individual and community levels. For example, in May 2024, a report from the Office for National Statistics, a UK-based government department, indicated that total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, marking a significant increase compared to the 0.9% growth recorded in 2022. Thus, the rise in healthcare expenditures is fueling the growth of the STD diagnostics market.

The advancement of STD diagnostics is a significant trend within the STD diagnostic market. Major players are enhancing testing facilities and techniques to facilitate quicker and more accurate diagnoses of sexually transmitted diseases. For example, in May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology firm, launched a fully automated, high-throughput molecular diagnostics platform for infectious diseases called the BD CORTM MX/PX System. This platform integrates and automates the molecular laboratory workflow, from sample processing to the delivery of diagnostic test results. The first test available on this new platform is the BD CTGCTV2 molecular assay, which is a single test capable of identifying the three most prevalent non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Key companies in the STD diagnostics market are focusing on developing innovative products, such as real-time PCR kits, to meet unmet medical needs and improve diagnostic capabilities. A real-time PCR kit consists of a collection of reagents utilized for conducting real-time polymerase chain reaction (qPCR), a sensitive and commonly employed technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, specifically designed for detecting Mycoplasma hominis and Treponema pallidum. These kits offer high sensitivity and specificity, user-friendliness, rapid turnaround times, and the capability to detect multiple pathogens in a single test.

In February 2024, Thyrocare, an India-based healthcare company, acquired Think Health Care for an undisclosed amount. With this acquisition, Thyrocare aims to strategically enhance its service offerings and market reach, especially in the home healthcare segment. Think Health Care is an India-based company specializing in diagnostic and preventive healthcare, known for providing at-home ECG services.

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

STD Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing; Other Types
  • 2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
  • 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
  • Subsegments:
  • 1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT); Antigen Tests
  • 2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests; Treponemal Tests
  • 3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT); Culture Tests
  • 4) By Herpes Simplex Virus Testing: PCR Tests; Serological Tests
  • 5) By Human Papilloma Virus Testing: HPV DNA Tests; HPV RNA Tests
  • 6) By Human Immunodeficiency Virus Testing: Antibody Tests; Antigen Or Antibody Tests; Nucleic Acid Tests (NAT)
  • 7) By Chancroid Testing: Culture Tests; Nucleic Acid Tests
  • 8) By Other Types: Various Emerging Tests
  • Companies Mentioned: Siemens AG; Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG; Hologic Inc.; Bio-Rad Laboratories Inc.; Becton Dickinson and Company; Thermo Fisher Scientific Inc.; Biocartis NV; Trinity Biotech PLC; Binx Health Inc.; NOWDiagnostics Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; BioMerieux SA; Chembio Diagnostic Systems Inc.; Corgenix Medical Corporation; Creative Diagnostics; Curetis AG; Daktari Diagnostics; Enzo Biochem Inc.; Fujirebio Diagnostics Inc.; GenePOC Inc.; GenMark Diagnostics Inc.; Grifols Diagnostic Solutions Inc.; Hain Lifescience GmbH; InDevR Inc.; Karius Inc.; Luminex Corporation; Meridian Bioscience Inc.; Mesa Biotech Inc.; Mobidiag Oy
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. STD Diagnostics Market Characteristics

3. STD Diagnostics Market Trends And Strategies

4. STD Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global STD Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global STD Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global STD Diagnostics Market Growth Rate Analysis
  • 5.4. Global STD Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global STD Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global STD Diagnostics Total Addressable Market (TAM)

6. STD Diagnostics Market Segmentation

  • 6.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Other Types
  • 6.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing
  • Point Of Care (PoC) Testing
  • 6.3. Global STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Centers
  • Homecare
  • 6.4. Global STD Diagnostics Market, Sub-Segmentation Of Chlamydia Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Amplification Tests (NAAT)
  • Antigen Tests
  • 6.5. Global STD Diagnostics Market, Sub-Segmentation Of Syphilis Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Plasma Reagin (RPR) Tests
  • Treponemal Tests
  • 6.6. Global STD Diagnostics Market, Sub-Segmentation Of Gonorrhea Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Amplification Tests (NAAT)
  • Culture Tests
  • 6.7. Global STD Diagnostics Market, Sub-Segmentation Of Herpes Simplex Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Tests
  • Serological Tests
  • 6.8. Global STD Diagnostics Market, Sub-Segmentation Of Human Papilloma Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • HPV DNA Tests
  • HPV RNA Tests
  • 6.9. Global STD Diagnostics Market, Sub-Segmentation Of Human Immunodeficiency Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antibody Tests
  • Antigen Or Antibody Tests
  • Nucleic Acid Tests (NAT)
  • 6.10. Global STD Diagnostics Market, Sub-Segmentation Of Chancroid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture Tests
  • Nucleic Acid Tests
  • 6.11. Global STD Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Various Emerging Tests

7. STD Diagnostics Market Regional And Country Analysis

  • 7.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific STD Diagnostics Market

  • 8.1. Asia-Pacific STD Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China STD Diagnostics Market

  • 9.1. China STD Diagnostics Market Overview
  • 9.2. China STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India STD Diagnostics Market

  • 10.1. India STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan STD Diagnostics Market

  • 11.1. Japan STD Diagnostics Market Overview
  • 11.2. Japan STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia STD Diagnostics Market

  • 12.1. Australia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia STD Diagnostics Market

  • 13.1. Indonesia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea STD Diagnostics Market

  • 14.1. South Korea STD Diagnostics Market Overview
  • 14.2. South Korea STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe STD Diagnostics Market

  • 15.1. Western Europe STD Diagnostics Market Overview
  • 15.2. Western Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK STD Diagnostics Market

  • 16.1. UK STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany STD Diagnostics Market

  • 17.1. Germany STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France STD Diagnostics Market

  • 18.1. France STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy STD Diagnostics Market

  • 19.1. Italy STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain STD Diagnostics Market

  • 20.1. Spain STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe STD Diagnostics Market

  • 21.1. Eastern Europe STD Diagnostics Market Overview
  • 21.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia STD Diagnostics Market

  • 22.1. Russia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America STD Diagnostics Market

  • 23.1. North America STD Diagnostics Market Overview
  • 23.2. North America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA STD Diagnostics Market

  • 24.1. USA STD Diagnostics Market Overview
  • 24.2. USA STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada STD Diagnostics Market

  • 25.1. Canada STD Diagnostics Market Overview
  • 25.2. Canada STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America STD Diagnostics Market

  • 26.1. South America STD Diagnostics Market Overview
  • 26.2. South America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil STD Diagnostics Market

  • 27.1. Brazil STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East STD Diagnostics Market

  • 28.1. Middle East STD Diagnostics Market Overview
  • 28.2. Middle East STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa STD Diagnostics Market

  • 29.1. Africa STD Diagnostics Market Overview
  • 29.2. Africa STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. STD Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. STD Diagnostics Market Competitive Landscape
  • 30.2. STD Diagnostics Market Company Profiles
    • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. STD Diagnostics Market Other Major And Innovative Companies

  • 31.1. Hologic Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Becton Dickinson and Company
  • 31.4. Thermo Fisher Scientific Inc.
  • 31.5. Biocartis NV
  • 31.6. Trinity Biotech PLC
  • 31.7. Binx Health Inc.
  • 31.8. NOWDiagnostics Inc.
  • 31.9. Atlas Genetics Ltd.
  • 31.10. BioFire Diagnostics LLC
  • 31.11. BioMerieux SA
  • 31.12. Chembio Diagnostic Systems Inc.
  • 31.13. Corgenix Medical Corporation
  • 31.14. Creative Diagnostics
  • 31.15. Curetis AG

32. Global STD Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The STD Diagnostics Market

34. Recent Developments In The STD Diagnostics Market

35. STD Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 STD Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 STD Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 STD Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer